During the past decade, Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" are "Breast Cancer" (5 trials), "Colorectal Cancer" (2 trials), "B-cell Lymphoma" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" in a lesser frequency.

Most popular intervention types in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Pertuzumab" (4 trials), "Placebo" (4 trials), "Trastuzumab" (4 trials), "Bevacizumab" (2 trials) and "Capecitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".